Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$245,097
+$33,262 QoQ
Shares Held
974
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#3,795
of 4,153 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hickory Point Bank & Trust holds $3,656,003 across 10 Drug Manufacturers - General names. ABBV ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,050 | $1,291,424 | |
| 2 | JNJ |
Johnson & Johnson
|
2,773 | $704,258 | |
| 3 | AMGN |
Amgen Inc
|
1,004 | $363,568 | |
| 4 | PFE |
Pfizer Inc
|
13,995 | $336,998 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
4,795 | $276,287 | |
| 6 | LLY |
ELI LILLY & Co
|
226 | $271,071 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
974 | $245,097 | |
| 8 | NVS |
Novartis AG
|
516 | $80,867 |
All Filings in ABBV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,097 | 974 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $211,835 | 974 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $222,549 | 974 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $234,318 | 1,012 | Shares | Sole | 2025-10-06 | |
| 2025-03-31 | $212,034 | 1,012 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||